Vincenzo Fragomeli
Nepean Hospital(AU)
Publications by Year
Research Areas
Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, Immune Cell Function and Interaction, HIV, Drug Use, Sexual Risk
Most-Cited Works
- → IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy(2009)1,814 cited
- → Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma(2021)446 cited
- → Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease(2015)173 cited
- → MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C(2016)128 cited
- → A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms(2019)16 cited
- → Real-World Efficacy and Safety of Ritonavir-Boosted Paritaprevir, Ombitasvir, Dasabuvir ± Ribavirin for Hepatitis C Genotype 1 – Final Results of the REV1TAL Study(2016)11 cited
- → Comparison between PSMA PET/CT and MRI for Characterizing Hepatocellular carcinoma: A Real-World Study(2023)8 cited
- → CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection(2013)5 cited
- → Very high real-world efficacy of ritonavir boosted paritaprevir with ombitasvir and dasabuvir +/− ribavirin in hepatitis C genotype 1 in patients with advanced fibrosis –Final results of the REV1TAL study(2017)1 cited
- 炎症:IFNλ4ではなく,IFN‐λ3がIFNL3‐IFNL4ハプロタイプ依存的に肝臓の炎症および線維症を仲介すると考えられる(2017)